A carregar...

Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans

BACKGROUND: Efavirenz is commonly used in Africa and is frequently associated with neurocognitive toxicity, which may compromise clinical outcomes. Older individuals are at increased risk for drug toxicity and clinical outcomes may be worse in older age, particularly among those individuals with cyt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Drug Metab Pharmacokinet
Main Authors: Torgersen, Jessie, Bellamy, Scarlett L., Ratshaa, Bakgaki, Han, Xiaoyan, Mosepele, Mosepele, Zuppa, Athena F, Vujkovic, Marijana, Steenhoff, Andrew, Bisson, Gregory P., Gross, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420397/
https://ncbi.nlm.nih.gov/pubmed/30168000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-018-0507-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!